Stockreport

Intellipharmaceutics to conduct new HAP study to support abuse-deterrent claim for Rexista [Seeking Alpha]

INTELLIPHARMACEUTICS  (IPCI) 
Last intellipharmaceutics earnings: 10/15 05:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.intellipharmaceutics.com
PDF In a statement issued after yesterday's negative Ad Com vote on oxycodone candidate Rexista, Intellipharmaceutics (NASDAQ: IPCI ) says it will conduct a new hum [Read more]